BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14506158)

  • 1. Overexpression of retinoic acid receptor alpha in hepatocellular carcinoma.
    Sano K; Takayama T; Murakami K; Saiki I; Makuuchi M
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3679-83. PubMed ID: 14506158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of insulin-like growth factor binding protein-3 in the retinoic acid receptor-alpha-mediated inhibition of hepatocellular carcinoma cell proliferation.
    Murakami K; Matsuura T; Hasumura S; Nagamori S; Yamada Y; Saiki I
    Cancer Lett; 2000 Apr; 151(1):63-70. PubMed ID: 10766424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.
    Xu XC; Liu X; Tahara E; Lippman SM; Lotan R
    Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
    Wan YJ; Cai Y; Magee TR
    Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid.
    Wu S; Zhang ZP; Zhang D; Soprano DR; Soprano KJ
    Exp Cell Res; 1997 Nov; 237(1):118-26. PubMed ID: 9417874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of MAFB and MAFF in Retinoid-Mediated Suppression of Hepatocellular Carcinoma Invasion.
    Tsuchiya H; Oura S
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H; Hong WK; Lotan R
    Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear retinoic acid receptors in the lacrimal gland.
    Ubels JL; Dennis MH; Rigatti BW; Vergnes JP; Beatty R; Kinchington PR
    Curr Eye Res; 1995 Nov; 14(11):1055-62. PubMed ID: 8585936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
    Kooistra T; Lansink M; Arts J; Sitter T; Toet K
    Eur J Biochem; 1995 Sep; 232(2):425-32. PubMed ID: 7556191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma.
    Yan TD; Wu H; Zhang HP; Lu N; Ye P; Yu FH; Zhou H; Li WG; Cao X; Lin YY; He JY; Gao WW; Zhao Y; Xie L; Chen JB; Zhang XK; Zeng JZ
    Cancer Res; 2010 Mar; 70(6):2285-95. PubMed ID: 20197465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells.
    Clifford JL; Petkovich M; Chambon P; Lotan R
    Mol Endocrinol; 1990 Oct; 4(10):1546-55. PubMed ID: 2178220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma.
    Meister B; Fink FM; Hittmair A; Marth C; Widschwendter M
    Anticancer Res; 1998; 18(3A):1777-86. PubMed ID: 9673404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of human tumor cells to retinoids or combined treatment with retinoids and ionizing radiation is not dependent on RAR-beta 2 induction.
    Blaese MA; Santo-Hoeltje L; Rodemann HP
    Strahlenther Onkol; 2003 Jun; 179(6):401-9. PubMed ID: 12789467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive androstane/active receptor is a target of retinoic acid receptor in humans.
    Saito K; Kobayashi K; Mizuno Y; Furihata T; Chiba K
    Biochem Pharmacol; 2010 Jul; 80(1):129-35. PubMed ID: 20211151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.